AIM ImmunoTech Inc.
AIM
$0.23
$0.00-0.09%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 18.18% | 4.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.18% | 4.76% | |||
| Cost of Revenue | 25.00% | -90.00% | |||
| Gross Profit | 16.67% | 194.74% | |||
| SG&A Expenses | 58.08% | -3.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 57.43% | -24.39% | |||
| Operating Income | -57.82% | 24.59% | |||
| Income Before Tax | -25.31% | 27.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.31% | 27.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.31% | 27.59% | |||
| EBIT | -57.82% | 24.59% | |||
| EBITDA | -36.74% | 24.96% | |||
| EPS Basic | 68.14% | 52.00% | |||
| Normalized Basic EPS | 68.14% | 52.01% | |||
| EPS Diluted | 68.14% | 52.00% | |||
| Normalized Diluted EPS | 68.14% | 52.01% | |||
| Average Basic Shares Outstanding | 293.41% | 50.85% | |||
| Average Diluted Shares Outstanding | 293.41% | 50.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||